Download Files:
CBP/p300-IN-14
SKU
HY-139861-Get quote
Category Reference compound
Tags Cancer, Epigenetic Reader Domain;Histone Acetyltransferase, Epigenetics
Products Details
Product Description
– CBP/p300-IN-14 is a potent inhibitor of CBP/EP300 (lysine acetyltransferase) with an IC50 of 3.3 nM (extracted from patent WO2021213521A1, compound 27)[1].
Web ID
– HY-139861
Shipping
– Room temperature
Molecular Formula
– C30H31F2N7O2
References
– [1]Wang, Lisha, et al. Cbp/ep300 inhibitor and use thereof. Patent WO2021213521A1.
CAS Number
– 2725036-10-0
Molecular Weight
– 559.61
SMILES
– O=C(C1=CC2=C(C=CC(N3C(CN(CC3)C)=O)=C2)C(N4C5=C(CCC4)C=C(C6=CN(C)N=C6)C(C(F)F)=C5)=N1)NC
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Epigenetic Reader Domain;Histone Acetyltransferase
Isoform
– CBP/p300
Pathway
– Epigenetics
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.